Multilocus sequence typing of Candida tropicalis shows clonal cluster enrichment in azole-resistant isolates from patients in Shanghai, China

Infection, Genetics and Evolution

Volumn 44, Issue , 2016, Pages 418-424

  Wang, Ying ^a,b   Shi, Ce ^a   Liu, Jin Yan ^a   Li, Wen Jing ^a   Zhao, Yue ^a   Xiang, Ming Jie ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ANHUI PROVINCIAL HOSPITAL   (China)

Author keywords

Antifungals; Candida tropicalis; Diploid sequence types; Multilocus sequence typing

Indexed keywords

FLUCONAZOLE; ITRACONAZOLE; TRIAZOLE DERIVATIVE; VORICONAZOLE; ANTIFUNGAL AGENT; PYRROLE DERIVATIVE;

ALGORITHM; ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA TROPICALIS; CHINA; CLUSTER ANALYSIS; CONTROLLED STUDY; DIPLOID SEQUENCE TYPE; DIPLOIDY; FUNGAL GENE; GENOTYPE; HOUSEKEEPING GENE; HUMAN; ICL1 GENE; MAJOR CLINICAL STUDY; MDR1 GENE; MOLECULAR CLONING; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; SAPT2 GENE; SAPT4 GENE; UNIVERSITY HOSPITAL; XYR1 GENE; ZWF1ALPHA GENE; ALLELE; CANDIDIASIS; CLASSIFICATION; DRUG EFFECTS; GENETICS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

ALLELES; ANTIFUNGAL AGENTS; AZOLES; CANDIDA TROPICALIS; CANDIDIASIS; CHINA; CLUSTER ANALYSIS; DRUG RESISTANCE, FUNGAL; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; PHYLOGENY;

EID: 84982712492     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2016.07.026     Document Type: Article

References (24)

1. Alcazar-Fuoli, L., Mellado, E., Current status of antifungal resistance and its impact on clinical practice. Br. J. Haematol. 166 (2014), 471–484.
2. Blumberg, H.M., Jarvis, W.R., Soucie, J.M., Edwards, J.E., Patterson, J.E., Pfaller, M.A., Rangel-Frausto, M.S., Rinaldi, M.G., Saiman, L., Wiblin, R.T., Wenzel, R.P., Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. 33, 2001, The National Epidemiology of Mycosis Survey. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 177–186.
3. Bougnoux, M.E., Morand, S., d'Enfert, C., Usefulness of multilocus sequence typing for characterization of clinical isolates of Candida albicans. J. Clin. Microbiol. 40 (2002), 1290–1297.
4. Chai, L.Y., Denning, D.W., Warn, P., Candida tropicalis in human disease. Crit. Rev. Microbiol. 36 (2010), 282–298.
5. Chen, C.Y., Chen, Y.C., Tang, J.L., Yao, M., Huang, S.Y., Tsai, W., Chen, Y.C., Shen, M.C., Wang, C.H., Tien, H.F., Hepatosplenic fungal infection in patients with acute leukemia in Taiwan: incidence, treatment, and prognosis. Ann. Hematol. 82 (2003), 93–97.
6. Chen, Y.C., Chang, S.C., Luh, K.T., Hsieh, W.C., Stable susceptibility of Candida blood isolates to fluconazole despite increasing use during the past 10 years. J. Antimicrob. Chemother. 52 (2003), 71–77.
7. Chen, K.W., Chen, Y.C., Lin, Y.H., Chou, H.H., Li, S.Y., The molecular epidemiology of serial Candida tropicalis isolates from ICU patients as revealed by multilocus sequence typing and pulsed-field gel electrophoresis. Infection, genetics and evolution: journal of molecular epidemiology and evolutionary genetics in infectious diseases 9 (2009), 912–920.
8. Chou, H.H., Lo, H.J., Chen, K.W., Liao, M.H., Li, S.Y., Multilocus sequence typing of Candida tropicalis shows clonal cluster enriched in isolates with resistance or trailing growth of fluconazole. Diagn. Microbiol. Infect. Dis. 58 (2007), 427–433.
9. Ding, X., Yan, D., Sun, W., Zeng, Z., Su, R., Su, J., Epidemiology and risk factors for nosocomial non-Candida albicans candidemia in adult patients at a tertiary care hospital in North China. Med. Mycol. 53 (2015), 684–690.
10. Jiang, C., Dong, D., Yu, B., Cai, G., Wang, X., Ji, Y., Peng, Y., Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China. J. Antimicrob. Chemother. 68 (2013), 778–785.
11. Kelly, S.L., Lamb, D.C., Kelly, D.E., Y132H substitution in Candida albicans sterol 14alpha-demethylase confers fluconazole resistance by preventing binding to haem. FEMS Microbiol. Lett. 180 (1999), 171–175.
12. Kontoyiannis, D.P., Vaziri, I., Hanna, H.A., Boktour, M., Thornby, J., Hachem, R., Bodey, G.P., Raad, I.I., Risk factors for Candida tropicalis fungemia in patients with cancer. 33, 2001, Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 1676–1681.
13. Lai, H.P., Chen, Y.C., Chang, L.Y., Lu, C.Y., Lee, C.Y., Lin, K.H., Huang, L.M., Invasive fungal infection in children with persistent febrile neutropenia. J. Formos. Med. Assoc. 104 (2005), 174–179.
14. Li, S.Y., Yang, Y.L., Lin, Y.H., Ko, H.C., Wang, A.H., Chen, K.W., Wang, C.W., Chi, H., Lo, H.J., Two closely related fluconazole-resistant Candida tropicalis clones circulating in Taiwan from 1999 to 2006. Microbial Drug Resistance, 15, 2009, 205–210 (Larchmont, N.Y.).
15. Ma, C.F., Li, F.Q., Shi, L.N., Hu, Y.A., Wang, Y., Huang, M., Kong, Q.Q., Surveillance study of species distribution, antifungal susceptibility and mortality of nosocomial candidemia in a tertiary care hospital in China. BMC Infect. Dis., 13, 2013, 337.
16. Magri, M.M., Gomes-Gouvea, M.S., de Freitas, V.L., Motta, A.L., Moretti, M.L., Shikanai-Yasuda, M.A., Multilocus sequence typing of Candida tropicalis shows the presence of different clonal clusters and fluconazole susceptibility profiles in sequential isolates from candidemia patients in Sao Paulo, Brazil. J. Clin. Microbiol. 51 (2013), 268–277.
17. Ng, K.P., Kuan, C.S., Kaur, H., Na, S.L., Atiya, N., Velayuthan, R.D., Candida species epidemiology 2000-2013: a laboratory-based report. Tropical Medicine & International Health: TM & IH 20 (2015), 1447–1453.
18. Pfaller, M.A., Andes, D., Diekema, D.J., Espinel-Ingroff, A., Sheehan, D., Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods. Drug Resistance Updates: Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy, 13, 2010, 180–195.
19. Pfaller, M.A., Andes, D., Arendrup, M.C., Diekema, D.J., Espinel-Ingroff, A., Alexander, B.D., Brown, S.D., Chaturvedi, V., Fowler, C.L., Ghannoum, M.A., Johnson, E.M., Knapp, C.C., Motyl, M.R., Ostrosky-Zeichner, L., Walsh, T.J., Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria. Diagn. Microbiol. Infect. Dis. 70 (2011), 330–343.
20. Silva, S., Negri, M., Henriques, M., Oliveira, R., Williams, D.W., Azeredo, J., Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance. FEMS Microbiol. Rev. 36 (2012), 288–305.
21. Tavanti, A., Davidson, A.D., Johnson, E.M., Maiden, M.C., Shaw, D.J., Gow, N.A., Odds, F.C., Multilocus sequence typing for differentiation of strains of Candida tropicalis. J. Clin. Microbiol. 43 (2005), 5593–5600.
22. Versalovic, J., Koeuth, T., Lupski, J.R., Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res. 19 (1991), 6823–6831.
23. Wu, J.Q., Zhu, L.P., Ou, X.T., Xu, B., Hu, X.P., Wang, X., Weng, X.H., Epidemiology and risk factors for non-Candida albicans candidemia in non-neutropenic patients at a Chinese teaching hospital. Med. Mycol. 49 (2011), 552–555.
24. Wu, Y., Zhou, H., Wang, J., Li, L., Li, W., Cui, Z., Chen, X., Cen, R., Lu, J., Cheng, Y., Analysis of the clonality of Candida tropicalis strains from a general hospital in Beijing using multilocus sequence typing. PLoS One, 7, 2012, e47767.